99mTc-labeled C2A domain of synaptotagmin I as a target-specific molecular probe for noninvasive imaging of acute myocardial infarction

Journal of Nuclear Medicine

Volumn 47, Issue 8, 2006, Pages 1367-1374

  Zhao, Ming ^a   Zhu, Xiaoguang ^a   Ji, Shundong ^b   Zhou, Jundong ^a   Ozker, Kutlan S ^a   Fang, Wei ^c   Molthen, Robert C ^a   Hellman, Robert S ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b SUZHOU UNIVERSITY   (China)

^c FUWAI HOSPITAL   (China)

Author keywords

Apoptosis; C2A domain; Myocardial infarction; Necrosis; Synaptotagmin I

Indexed keywords

2 IMINOTHIOLANE; RADIOISOTOPE; SYNAPTOTAGMIN 1 GLUTATHIONE TRANSFERASE N HYDROXY SUCCINIMIDE TC 99M; SYNAPTOTAGMIN 1 GLUTATHIONE TRANSFERASE TC 99M; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; FLUORESCEIN ISOTHIOCYANATE; GLUTATHIONE TRANSFERASE; SYNAPTOTAGMIN I; TECHNETIUM;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPSY; AUTORADIOGRAPHY; CELL DEATH; COLLIMATOR; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG HALF LIFE; HISTOLOGY; HUMAN; HUMAN CELL; IMAGING; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR PROBE; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; RAT; RISK; SCINTILLATION CAMERA; STAINING; ANIMAL; CHEMISTRY; HEART INFARCTION; LEUKEMIA CELL LINE; METABOLISM; NECROSIS; PATHOLOGY; PROTEIN TERTIARY STRUCTURE; REPERFUSION INJURY; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; FLUORESCEIN-5-ISOTHIOCYANATE; GLUTATHIONE TRANSFERASE; HUMANS; JURKAT CELLS; MALE; MYOCARDIAL INFARCTION; NECROSIS; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SYNAPTOTAGMIN I; TECHNETIUM;

EID: 33749049365     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239-257.
2. Kerr JF. History of the events leading to the formulation of the apoptosis concept. Toxicology. 2002;181-182:471-474.
3. Selivanova G. p53: fighting cancer. Curr Cancer Drug Targets. 2004;4:385-402.
4. Huang P, Heimbrook DC. Oncogene products as therapeutic targets for cancer. Curr Opin Oncol. 1997;9:94-100.
5. Gourley M, Williamson JS. Angiogenesis: new targets for the development of anticancer chemotherapies. Curr Pharm Des. 2000;6:417-439.
6. Song Z, Steller H. Death by design: mechanism and control of apoptosis. Trends Cell Biol. 1999;9:M49-M52.
7. Wyllie AH. Apoptosis: an overview. Br Med Bull. 1997;53:451-465.
8. Grutter MG. Caspases: key players in programmed cell death. Curr Opin Struct Biol. 2000;10:649-655.
9. Green DR. Apoptotic pathways: the roads to ruin. Cell. 1998;94:695-698.
10. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science. 1998;281:1312-1316.
11. Cohen GM. Caspases: the executioners of apoptosis. Biochem J. 1997;326:1-16.
12. Kostin S, Pool L, Elsasser A, et al. Myocytes die by multiple mechanisms in failing human hearts. Circ Res. 2003;92:715-724.
13. Freude B, Masters TN, Kostin S, et al. Cardiomyocyte apoptosis in acute and chronic conditions. Basic Res Cardiol. 1998;93:85-89.
14. Khaw BA. The current role of infarct avid imaging. Semin Nucl Med. 1999;29:259-270.
15. Williamson P, Schlegel RA. Transbilayer phospholipid movement and the clearance of apoptotic cells. Biochim Biophys Acta. 2002;1585:53-63.
16. +/phospholipid binding. J Biol Chem. 1993;268:26386-26390.
17. Zhao M, Beauregard DA, Loizou L, et al. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat Med. 2001;7:1241-1244.
18. Jung HI, Kettunen MI, Davletov B, et al. Detection of apoptosis using the C2A domain of synaptotagmin I. Bioconjug Chem. 2004;15:983-987.
19. Blankenberg FG, Katsikis PD, Tait JF, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci U S A. 1998;95:6349-6354.
20. Ohtsuki K, Akashi K, Aoka Y, et al. Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis. Eur J Nucl Med. 1999;26:1251-1258.
21. Petrovsky A, Schellenberger E, Josephson L, et al. Near-infrared fluorescent imaging of tumor apoptosis. Cancer Res. 2003;63:1936-1942.
22. Lahorte CMM, VanderHeyden JL, Steinmetz N, et al. Apoptosis-detecting radioligands: current state of the art and future perspectives. Eur J Nucl Med. 2004;31:887-919.
23. 99mTc-annexin V. J Nucl Med. 2005;46:807-815.
24. 99mTc. Bioconjug Chem. 2000;11:918-925.
25. Hofstra L, Liem IH, Dumont EA, et al. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet. 2000;356:209-212.
26. Thimister PW, Hofstra L, Liem IH, et al. In vivo detection of cell death in the area at risk in acute myocardial infarction. J Nucl Med. 2003;44:391-396.
27. Saeed M, van Dijke CF, Mann JS, et al. Histologic confirmation of microvascular hyperpermeability to macromolecular MR contrast medium in reperfused myocardial infarction. J Magn Reson Imaging. 1998;8:561-567.
28. Schwitter J, Saeed M, Wendland MF, et al. Influence of severity of myocardial injury on distribution of macromolecules: extravascular versus intravascular gadolinium-based magnetic resonance contrast agents. J Am Coll Cardiol. 1997;30:1086-1094.
29. 2 fragments with technetium-99m. Nucl Med Biol. 1995;22:451-457.
30. Boyne AF, Ellman GL. A methodology for analysis of tissue sulfhydryl components. Anal Biochem. 1972;46:639-653.
31. 99mTc-labeled annexin V. J Nucl Med. 2004;45:1536-1541.
32. Sopkova J, Renouard M, Lewit-Bentley A. The crystal structure of a new high-calcium form of annexin V. J Mol Biol. 1993;234:816-825.
33. Huber R, Romisch J, Paques EP. The crystal and molecular structure of human annexin V, an anticoagulant protein that binds to calcium and membranes. EMBO J. 1990;9:3867-3874.
34. Huber R, Schneider M, Mayr I, et al. The calcium binding sites in human annexin V by crystal structure analysis at 2.0 Å resolution: implications for membrane binding and calcium channel activity. FEBS Lett. 1990;275:15-21.
35. +/phospholipid-binding fold. Cell. 1995;80:929-938.